Applied Genetic Technologies Corp Company Profile (NASDAQ:AGTC)

About Applied Genetic Technologies Corp (NASDAQ:AGTC)

Applied Genetic Technologies Corp logoApplied Genetic Technologies Corporation is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. As of March 31, 2016, its product candidates included treatments for X-linked retinoschisis (XLRS), over two forms of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP). As of March 31, 2016, the Company was engaged in developing three discovery programs, targeting three indications based on its adeno-associated virus vector technologies. XLRS is an inherited retinal degenerative disease caused by mutations in the retinoschisis1 (RS1) gene. Achromatopsia is an inherited condition that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and reduced or complete loss of color discrimination, achromatopsia is caused by mutations in any of several genes. The Company is also developing Alpha-1 Antitrypsin Deficiency (Alpha 1).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AGTC
  • CUSIP: N/A
  • Web: www.agtc.com
Capitalization:
  • Market Cap: $96.71 million
  • Outstanding Shares: 18,076,000
Average Prices:
  • 50 Day Moving Avg: $5.89
  • 200 Day Moving Avg: $7.76
  • 52 Week Range: $5.00 - $17.41
P/E:
  • Trailing P/E Ratio: 12.77
  • Foreward P/E Ratio: -7.99
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $43.24 million
  • Price / Sales: 2.24
  • Book Value: $6.55 per share
  • Price / Book: 0.82
Profitability:
  • EBIDTA: $8.04 million
  • Net Margins: 22.20%
  • Return on Equity: 9.32%
  • Return on Assets: 5.88%
Debt:
  • Current Ratio: 2.80%
  • Quick Ratio: 2.80%
Misc:
  • Average Volume: 147,316 shs.
  • Beta: 1.69
  • Short Ratio: 2.57
 

Frequently Asked Questions for Applied Genetic Technologies Corp (NASDAQ:AGTC)

What is Applied Genetic Technologies Corp's stock symbol?

Applied Genetic Technologies Corp trades on the NASDAQ under the ticker symbol "AGTC."

How were Applied Genetic Technologies Corp's earnings last quarter?

Applied Genetic Technologies Corp (NASDAQ:AGTC) issued its earnings results on Wednesday, May, 10th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.04. The company earned $8.39 million during the quarter, compared to analyst estimates of $10.39 million. Applied Genetic Technologies Corp had a return on equity of 9.32% and a net margin of 22.20%. The business's revenue was down 30.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.11 earnings per share. View Applied Genetic Technologies Corp's Earnings History.

Where is Applied Genetic Technologies Corp's stock going? Where will Applied Genetic Technologies Corp's stock price be in 2017?

8 brokerages have issued 12 month price objectives for Applied Genetic Technologies Corp's stock. Their predictions range from $11.00 to $16.00. On average, they expect Applied Genetic Technologies Corp's stock price to reach $14.43 in the next twelve months. View Analyst Ratings for Applied Genetic Technologies Corp.

What are analysts saying about Applied Genetic Technologies Corp stock?

Here are some recent quotes from research analysts about Applied Genetic Technologies Corp stock:

  • 1. According to Zacks Investment Research, "Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida. " (5/11/2017)
  • 2. Rodman & Renshaw analysts commented, "A leader in AAV development; first-in-man data soon and critical to investment case. AGTC's AAV (adeno-associated virus) platform is based on a proprietary viral composition and manufacturing process that are backed by strong intellectual property positions. AGTC has the capability to target specific tissue types and drive gene expression appropriate for that tissue. We believe that there is great potential to treat an array of disorders that are monogenic (single gene) and autosomal recessive or X-linked. The company is currently targeting orphan ophthalmological indications with the goal of addressing the underlying biology of the disorder.Plenty of cash to fund development. We believe the preclinical data in hand support our projected outcome for positive results from the ongoing clinical programs. We are quickly approaching critical first-in-man data in mid-2017 from the company's lead program in XLRS and initial clinical data from the ACHM program by year-end 2017. We believe these data should help correct the valuation disconnect we call to investors' attention where the stock is trading below the company's cash balance, primarily due to the early stage nature of the platform. Additionally, the company has approximately two years of cash on hand to deliver to our development projections; furthermore, the trajectory should create inflection points that include the clinical data points mentioned as well as advancing more products into development." (3/15/2017)

Who are some of Applied Genetic Technologies Corp's key competitors?

Who owns Applied Genetic Technologies Corp stock?

Applied Genetic Technologies Corp's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (0.00%), Acadian Asset Management LLC (3.95%), Vanguard Group Inc. (0.00%), Renaissance Technologies LLC (0.00%), AQR Capital Management LLC (1.03%) and Eventide Asset Management LLC (1.02%). Company insiders that own Applied Genetic Technologies Corp stock include Ivana Magovcevic, Jeffrey D Chulay, Lawrence E Bullock, Mark S Shearman and Stephen W Potter. View Institutional Ownership Trends for Applied Genetic Technologies Corp.

Who sold Applied Genetic Technologies Corp stock? Who is selling Applied Genetic Technologies Corp stock?

Applied Genetic Technologies Corp's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Eventide Asset Management LLC, American Century Companies Inc., AQR Capital Management LLC, Oxford Asset Management, Citadel Advisors LLC, Trexquant Investment LP and Granite Investment Partners LLC. View Insider Buying and Selling for Applied Genetic Technologies Corp.

Who bought Applied Genetic Technologies Corp stock? Who is buying Applied Genetic Technologies Corp stock?

Applied Genetic Technologies Corp's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, Iguana Healthcare Management LLC, Nine Chapters Capital Management LLC, Morgan Stanley, TFS Capital LLC, Prudential Financial Inc. and ClariVest Asset Management LLC. Company insiders that have bought Applied Genetic Technologies Corp stock in the last two years include Ivana Magovcevic, Lawrence E Bullock, Mark S Shearman and Stephen W Potter. View Insider Buying and Selling for Applied Genetic Technologies Corp.

How do I buy Applied Genetic Technologies Corp stock?

Shares of Applied Genetic Technologies Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Applied Genetic Technologies Corp stock cost?

One share of Applied Genetic Technologies Corp stock can currently be purchased for approximately $5.35.

Analyst Ratings

Consensus Ratings for Applied Genetic Technologies Corp (NASDAQ:AGTC) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $14.43 (169.69% upside)

Analysts' Ratings History for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/10/2017Cantor FitzgeraldSet Price TargetHold$15.00LowView Rating Details
5/11/2017Stifel NicolausLower Price TargetBuy -> Buy$18.00 -> $15.00HighView Rating Details
3/15/2017Rodman & RenshawInitiated CoverageBuy -> Buy$16.00HighView Rating Details
2/9/2017WedbushReiterated RatingOutperform$15.00N/AView Rating Details
2/9/2017BMO Capital MarketsLower Price TargetBuy$20.00 -> $14.00N/AView Rating Details
11/9/2016Roth CapitalUpgradeNeutral -> Buy$12.00 -> $15.00N/AView Rating Details
9/26/2016Janney Montgomery ScottUpgradeSell -> Neutral$11.00N/AView Rating Details
9/13/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
1/10/2016Chardan CapitalReiterated RatingBuy$25.00N/AView Rating Details
(Data available from 5/24/2015 forward)

Earnings

Earnings History for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Earnings by Quarter for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Earnings History by Quarter for Applied Genetic Technologies Corp (NASDAQ:AGTC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q3 2017($0.01)($0.05)$10.39 million$8.39 millionViewN/AView Earnings Details
2/8/2017Q217$0.02$0.11$11.10 million$10.90 millionViewListenView Earnings Details
11/8/2016Q117($0.10)$0.20$10.21 million$11.80 millionViewListenView Earnings Details
9/12/2016Q416$0.07$0.15$13.10 million$12.10 millionViewListenView Earnings Details
5/9/2016Q3$0.05$0.11$12.98 million$12.00 millionViewN/AView Earnings Details
2/8/2016Q216($0.19)$0.17$8.76 million$12.20 millionViewN/AView Earnings Details
11/5/2015Q1($0.20)($0.53)$5.91 million$11.06 millionViewN/AView Earnings Details
9/10/2015Q415($0.41)($0.48)$0.63 million$0.71 millionViewN/AView Earnings Details
5/11/2015Q315($0.33)($0.38)$0.59 million$0.28 millionViewN/AView Earnings Details
2/11/2015Q215($0.39)($0.28)$0.45 million$0.65 millionViewN/AView Earnings Details
11/12/2014Q115($0.29)($0.34)$258.00 million$705.00 millionViewN/AView Earnings Details
9/26/2014Q414($0.29)($0.32)$0.23 million$0.12 millionViewN/AView Earnings Details
5/14/2014Q114($0.37)($25.45)$0.15 million$0.23 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Applied Genetic Technologies Corp (NASDAQ:AGTC)
2017 EPS Consensus Estimate: ($0.36)
2018 EPS Consensus Estimate: ($0.94)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172($0.45)$0.09($0.18)
Q2 20172($0.04)($0.02)($0.03)
Q3 20172($0.14)$0.04($0.05)
Q4 20172($0.16)($0.04)($0.10)
Q1 20181($0.12)($0.12)($0.12)
Q2 20181$0.08$0.08$0.08
Q3 20181($0.27)($0.27)($0.27)
Q4 20181($0.63)($0.63)($0.63)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Applied Genetic Technologies Corp (NASDAQ:AGTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Insider Ownership Percentage: 2.46%
Institutional Ownership Percentage: 56.91%
Insider Trades by Quarter for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Institutional Ownership by Quarter for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Insider Trades by Quarter for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2016Ivana MagovcevicDirectorBuy3,000$9.63$28,890.00View SEC Filing  
11/1/2016Jeffrey D ChulayVPSell1,000$7.05$7,050.00View SEC Filing  
9/22/2016Mark S ShearmanInsiderBuy3,000$8.87$26,610.00View SEC Filing  
9/20/2016Stephen W PotterInsiderBuy1,400$8.89$12,446.00View SEC Filing  
9/19/2016Lawrence E BullockCFOBuy10,000$8.75$87,500.00View SEC Filing  
2/23/2015Plc GlaxosmithklineMajor ShareholderSell503,150$22.00$11,069,300.00View SEC Filing  
1/23/2015Daniel L MenichellaVPSell1,996$24.90$49,700.40View SEC Filing  
12/22/2014Daniel L MenichellaVPSell9,000$20.83$187,470.00View SEC Filing  
4/1/2014Interwest Partners Viii LpMajor ShareholderBuy75,376$12.00$904,512.00View SEC Filing  
4/1/2014Jill CarrollDirectorBuy103,762$12.00$1,245,144.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Latest Headlines for Applied Genetic Technologies Corp (NASDAQ:AGTC)
Source:
DateHeadline
americanbankingnews.com logoFY2017 EPS Estimates for Applied Genetic Technologies Corp (AGTC) Reduced by Analyst
www.americanbankingnews.com - May 15 at 8:54 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Price Target Lowered to $15.00 at Stifel Nicolaus
www.americanbankingnews.com - May 14 at 12:32 AM
americanbankingnews.com logoBrokers Offer Predictions for Applied Genetic Technologies Corp's Q2 2018 Earnings (AGTC)
www.americanbankingnews.com - May 12 at 4:50 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Downgraded by Zacks Investment Research
www.americanbankingnews.com - May 11 at 4:21 PM
businesswire.com logoAxcella Announces the Appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., as Executive Vice President, Chief Strategy and Corporate Development Officer
www.businesswire.com - May 11 at 3:39 PM
reuters.com logoBRIEF-Applied Genetic Technologies quarterly revenue $8.4 million
www.reuters.com - May 11 at 3:39 PM
finance.yahoo.com logoAGTC Presents New Data on its AAV-Based Gene Therapies for the Treatment of Achromatopsia and X-Linked Retinitis Pigmentosa at the American Society of Gene and Cell Therapy 20th Annual Meeting
finance.yahoo.com - May 11 at 3:39 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Given a $15.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - May 11 at 2:56 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Issues Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - May 10 at 9:14 PM
finance.yahoo.com logoAGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017
finance.yahoo.com - May 10 at 8:35 PM
finance.yahoo.com logoApplied Genetic Technologies posts 3Q loss
finance.yahoo.com - May 10 at 8:35 PM
nasdaq.com logoAGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at
www.nasdaq.com - May 10 at 3:35 PM
finance.yahoo.com logoInvestor Network: Applied Genetic Technologies Corp. to Host Earnings Call
finance.yahoo.com - May 10 at 3:35 PM
americanbankingnews.com logo$9.55 Million in Sales Expected for Applied Genetic Technologies Corp (AGTC) This Quarter
www.americanbankingnews.com - May 10 at 11:34 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - May 9 at 10:52 AM
finance.yahoo.com logoAGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
finance.yahoo.com - May 9 at 9:24 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Expected to Announce Earnings of -$0.02 Per Share
www.americanbankingnews.com - May 8 at 10:50 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - May 8 at 8:32 AM
finance.yahoo.com logoAGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 10, 2017
finance.yahoo.com - May 2 at 3:27 PM
americanbankingnews.com logoSomewhat Favorable Media Coverage Unlikely to Affect Applied Genetic Technologies Corp (AGTC) Share Price
www.americanbankingnews.com - May 2 at 10:14 AM
finance.yahoo.com logoETFs with exposure to Applied Genetic Technologies Corp. : May 1, 2017
finance.yahoo.com - May 2 at 6:52 AM
reuters.com logoBRIEF-Applied Genetic Technologies says on April 26 CFO Lawrence Bullock said will retire in near future
www.reuters.com - May 1 at 3:27 PM
streetinsider.com logoApplied Genetic Technologies (AGTC) CFO Lawrence E. Bullock to Retire
www.streetinsider.com - May 1 at 3:27 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Earns News Impact Score of 0.31
www.americanbankingnews.com - April 28 at 11:02 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Receiving Somewhat Favorable Press Coverage, AlphaOne Reports
www.americanbankingnews.com - April 25 at 2:30 PM
americanbankingnews.com logoSomewhat Critical Media Coverage Likely to Affect Applied Genetic Technologies Corp (AGTC) Stock Price
www.americanbankingnews.com - April 21 at 9:01 AM
finance.yahoo.com logoAGTC to Present at the 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017
finance.yahoo.com - April 20 at 3:27 PM
finance.yahoo.com logoETFs with exposure to Applied Genetic Technologies Corp. : April 19, 2017
finance.yahoo.com - April 19 at 3:25 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Expected to Announce Quarterly Sales of $9.55 Million
www.americanbankingnews.com - April 19 at 11:41 AM
americanbankingnews.com logoSomewhat Negative Press Coverage Likely to Affect Applied Genetic Technologies Corp (AGTC) Stock Price
www.americanbankingnews.com - April 18 at 10:48 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Expected to Post Earnings of -$0.02 Per Share
www.americanbankingnews.com - April 17 at 11:54 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Receives Media Impact Score of 0.01
www.americanbankingnews.com - April 15 at 8:53 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - April 14 at 3:10 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 14 at 11:06 AM
thestreet.com logoApplied Genetic Technologies Enters Oversold Territory (AGTC)
www.thestreet.com - April 12 at 3:22 PM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Short Interest Up 8.0% in March
www.americanbankingnews.com - April 8 at 7:26 AM
finance.yahoo.com logoETFs with exposure to Applied Genetic Technologies Corp. : April 5, 2017
finance.yahoo.com - April 7 at 7:21 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Receives New Coverage from Analysts at Rodman & Renshaw
www.americanbankingnews.com - March 21 at 8:28 AM
americanbankingnews.com logoApplied Genetic Technologies Corp (AGTC) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 20 at 1:19 PM
seekingalpha.com logoApplied Genetic Technologies (AGTC) Presents At 29th Annual ROTH Conference
seekingalpha.com - March 15 at 8:30 PM
streetinsider.com logoUPDATE: Rodman & Renshaw Starts Applied Genetic Technologies Corp. (AGTC) at Buy - StreetInsider.com
www.streetinsider.com - March 15 at 3:29 PM
finance.yahoo.com logoCoverage initiated on Applied Genetic Technologies by Rodman & Renshaw
finance.yahoo.com - March 15 at 3:28 PM
americanbankingnews.com logoStock Analysts’ Updated EPS Estimates for March, 15th (AEG, AGTC, AMFW, AMGN, AMZN, ANTO, AZN, BAB, BIFF, BRK)
www.americanbankingnews.com - March 15 at 8:19 AM
americanbankingnews.com logoZacks Investment Research Downgrades Applied Genetic Technologies Corp (AGTC) to Hold
www.americanbankingnews.com - March 13 at 10:06 AM
finance.yahoo.com logoSpectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat
finance.yahoo.com - March 9 at 3:28 PM
zacks.com logoApplied Genetic Technologies (AGTC) Shares March Higher, Can It Continue?
www.zacks.com - March 6 at 11:16 AM
nasdaq.com logoAGTC to Present at the 29th Annual ROTH Conference on March 14, 2017 - Nasdaq
www.nasdaq.com - March 3 at 3:39 PM
finance.yahoo.com logoAGTC to Present at the 29th Annual ROTH Conference on March 14, 2017
finance.yahoo.com - March 3 at 3:39 PM
biz.yahoo.com logoAPPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 2 at 8:39 PM
finance.yahoo.com logoAPPLIED GENETIC TECHNOLOGIES CORP Financials
finance.yahoo.com - February 14 at 3:40 PM

Social

Chart

Applied Genetic Technologies Corp (AGTC) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by MarketBeat.com Staff